Two critical characteristics of breast cancer that are important to treatment can be identified by measuring gene expression in the tumor, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reports in Lancet Oncology online. Researchers developed and validated a new genomic microarray test that identifies whether a [...]
Filed under: Affymetrix, bioinformatics, bioinformatics blog, bioinformatics software, cancer, cancer microarray, clinical diagnostics, clinical microarray, Clinical microarrays, custom microarray, DNA, DNA microarray, drug development, drug discoverry, drug resistance, gene expression, genetics, genotyping, microaray blog, microarray, microarray analysis, microarray for clinical diagnostics, personalized medicine, Pharmacogenomics | 3 Comments »
